Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
Clinical trial NCT03293030 · COMPLETED
Trial details
- NCT number
- NCT03293030
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-22
- Primary completion
- 2023-02-23
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.